Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Observational

Cannabis Use Patterns Among Young Adults and Associations With Social and Health Outcomes.

NCT07063589 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2025-09-16
Last updated
2025-12-24

Condition(s) studied

Cannabis Use

Investigational drug(s) / intervention(s)

Mobile application

Mobile application: Cannabis use patterns and their resulting subjective experiences, along with social and health-related correlates will be collected in real time using a mobile application specifically designed for this study by a local custom software development company (Osedea, Montreal).

Study summary

The purpose of this study is to identify and characterize patterns of non-therapeutic cannabis consumption and their variation in time in regular/daily users aged 18-24 years using a multi-factor approach (frequency of use, product types, cannabinoid dosages) over a two-year period.

Eligibility

Sex
ALL
Min age
18 Years
Max age
24 Years
Healthy volunteers
Accepted
Inclusion Criteria: * 18 to 24 years of age; * Cannabis use frequency of at least 1 day/week in the past three months; * Ability to speak and read French or English; * willingness to comply with all study procedures; * access to a mobile phone. Exclusion Criteria: * Planned extended absence during study period (e.g. pending legal action, surgery, incarceration, inpatient residential program) which, in the opinion of the research staff, might prevent completion of the study; * Current or anticipated treatment for cannabis use disorder, confirmed via self-report; * Medical document authorizing the use of cannabis for medical purposes; * Participation in clinical studies or undergoing other investigational procedures involving cannabis or cannabinoids administration.

Primary outcome measure(s)

  • Cannabis use patterns — Baseline
    Primary outcome measures of this study are specific assessments of cannabis use patterns, measured at baseline and daily using the mobile app. Primary outcome assessments related to cannabis use patterns will be tracked daily, taking advantage of a short but detailed series of questions taking approximately 1-5 minutes to answer, depending on the number of consumption events during the day. Participants will be advised to provide information even during non-consumption days, which in these cases will be limited to their general appreciation of the day, in addition to the fact that they did not consume that day. Participants will be able to retrospectively enter daily cannabis consumption data up to a maximum of seven days in the past, to minimize recall bias.
  • Trajectories of consumption patterns over time_Route of administration — From baseline (Day 1) up to two year (Day 730)
    The investigators will use weekly reports on participants' habits surrounding cannabis use in the form of logbook entries, covering the route of administration for each product. This information will be collected for each consumption session during a use day.
  • Trajectories of consumption patterns over time_product type — From baseline (Day 1) up to two year (Day 730)
    The investigators will use weekly reports on participants' habits surrounding cannabis use in the form of logbook entries, covering the product type for each product. This information will be collected for each consumption session during a use day.
  • Trajectories of consumption patterns over time_THC constituent (%) — From baseline (Day 1) up to two year (Day 730)
    The investigators will use weekly reports on participants' habits surrounding cannabis use in the form of logbook entries, covering the THC constituent (%) for each product. This information will be collected for each consumption session during a use day.
  • Trajectories of consumption patterns over time_CBD constituent (%) — From baseline (Day 1) up to two year (Day 730)
    The investigators will use weekly reports on participants' habits surrounding cannabis use in the form of logbook entries, covering the CBD constituent (%) for each product. This information will be collected for each consumption session during a use day.
  • Trajectories of consumption patterns over time_amount per use — From baseline (Day 1) up to two year (Day 730)
    The investigators will use weekly reports on participants' habits surrounding cannabis use in the form of logbook entries, covering the amount per use for each product. This information will be collected for each consumption session during a use day.
  • Trajectories of consumption patterns over time_supply source — From baseline (Day 1) up to two year (Day 730)
    The investigators will also capture information on supply source (choices are: cultivated by me or for me, family member or friend or acquaintance, SQDC, legal source from another province, health Canada licensed producer, illegal market) for each product used in the logbook.

Trial sites (1)

FacilityCityRegionStatus
Centre de recherche du Centre Hospitalier Universitaire de Montréal Montreal Quebec Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07063589 on ClinicalTrials.gov ↗ ← All trials in Canada